Form 4: CorMedix Executive Reports Stock Transaction
Insider Transaction (Form 4)
Kaufman Beth Zelnick, Chief Legal Officer of CorMedix Inc., reported a transaction in 8,424 shares of common stock on August 29, 2026.
Summary
- Tax/exercise-price withholding: disposed of 8,424 Common Stock at $8.30 ($69,919) on August 29, 2026; holds 260,684 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kaufman Beth Zelnick — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-29 | Tax/exercise-price withholding | Common Stock | 8,424 | $8 | $69.9K | 260,684 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-29 | Tax/exercise-price withholding (8,424 shares) |
Keywords
insider transaction, Form 4, CRMD, CorMedix Inc., neutral, Kaufman Beth Zelnick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.